PHARMACY

Report claims that 18 percent of Boomers will suffer age-related cognitive issues

BY Drew Buono

CHICAGO According to a new report entitled “2008 Alzheimer’s Disease Facts and Figures,” about 18 percent, or 14 million, of 79 million American who are considered baby boomers can expect to develop Alzheimer’s disease or some other type of dementia in their lifetime, according to USA Today.

Age is the single biggest risk factor for the disease, with the likelihood of developing Alzheimer’s doubling every five years after the age of 65. The report states that, one out of eight boomers will be diagnosed with Alzheimer’s, the most common type of dementia, at some point. If no cure for Alzheimer’s is found, the nation will be faced with a half-million new cases of Alzheimer’s in 2010 and nearly a million per year by the middle of the century.

Also, the report notes that as of now, 5.2 million people have the disease and that as many as 500,000 Americans are diagnosed with it before the age of 65.

Healthcare costs play a major factor in Alzheimer’s as well. In 2005, Medicare spent $91 billion on Alzheimer’s and other dementias, and spending could jump to $160 billion by 2010 and $189 billion by 2015.

Treatments that could delay the age of onset for Alzheimer’s could save Medicare billions.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

QLT to sell off Aczone following FDA decision

BY Drew Buono

VANCOUVER, Canada QLT has announced that it will proceed with its plan to sell its topical acne treatment Aczone after the Food and Drug Administration removed key blood monitoring requirements for the treatment, according to Reuters.

The company is selling the drug as part of a multi-step process to return it to its core business of treating eye diseases. Recently the company had been delving into acne and prostate cancer treatments.

Already several companies have expressed interest in Aczone and QLT predicts the drug will be sold within the next quarter or two.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Safeway offers Shingles vaccination

BY DSN STAFF

PLEASANTON, Calif. Safeway is offering immunization against Shingles, a disease that commonly affects people over 50 or people with compromised immune systems, at 700 pharmacies in the states of Ark., Calif., Colo., Del., Hawaii, Ind., Ill., Mont., Neb., Nev., Ore., Pa., Texas, Va. ,W.Va. and Wash. The vaccine will be provided on a walk-in basis at in-store pharmacies.

“The only way to prevent against contracting this debilitating disease is to get a single shot. By administering vaccines on site, Safeway is making it easy for anyone to protect themselves,” said Dave Fong, Safeway senior vice president of pharmacy. “Receiving a shingles vaccination is as easy as stopping at the pharmacy during your regular shopping trip.” 

Safeway also offers full-service adult and adolescent immunization services for the prevention of such ailments as tetanus, hepatitis, pneumococcal, meningococcal and more.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?